# Cardiovascular Implications of COVID-19

> **NCT04435457** · — · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 42 (actual)

## Conditions studied

- SARS-CoV 2
- SARS Pneumonia
- COVID-19
- SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
- Cardiac Complication

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04435457
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-01
- **Primary completion:** 2023-05-20
- **Final completion:** 2023-05-20
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** COVID-19 natural history has changed and no further patients meet eligibility as hospitalizations are at a minimum.
- **Last updated:** 2023-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04435457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04435457, "Cardiovascular Implications of COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04435457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*